Weiping Zhou

19.7k total citations · 6 hit papers
225 papers, 12.7k citations indexed

About

Weiping Zhou is a scholar working on Molecular Biology, Hepatology and Surgery. According to data from OpenAlex, Weiping Zhou has authored 225 papers receiving a total of 12.7k indexed citations (citations by other indexed papers that have themselves been cited), including 83 papers in Molecular Biology, 79 papers in Hepatology and 68 papers in Surgery. Recurrent topics in Weiping Zhou's work include Hepatocellular Carcinoma Treatment and Prognosis (73 papers), RNA modifications and cancer (35 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). Weiping Zhou is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (73 papers), RNA modifications and cancer (35 papers) and Cholangiocarcinoma and Gallbladder Cancer Studies (35 papers). Weiping Zhou collaborates with scholars based in China, United States and Hong Kong. Weiping Zhou's co-authors include Fu Yang, Shuhan Sun, Yuan Yang, Shengxian Yuan, Ji‐hang Yuan, Jinzhao Ma, Qingguo Xu, Xisong Huo, Chuanchuan Zhou and Qi-fei Tao and has published in prestigious journals such as New England Journal of Medicine, Journal of Biological Chemistry and Nature Communications.

In The Last Decade

Weiping Zhou

218 papers receiving 12.6k citations

Hit Papers

A Long Noncoding RNA Activated by TGF-β Promotes the Inva... 2011 2026 2016 2021 2014 2017 2016 2011 2018 400 800 1.2k
What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

  1. A Long Noncoding RNA Activated by TGF-β Promotes the Invasion-Metastasis Cascade in Hepatocellular Carcinoma
    2014 1.3k citations Fu Yang, Yingjun Guo et al. profile →
  2. Circular RNA circMTO1 acts as the sponge of microRNA‐9 to suppress hepatocellular carcinoma progression
    2017 939 citations Weiping Zhou et al. Hepatology profile →
  3. METTL14 suppresses the metastatic potential of hepatocellular carcinoma by modulating N 6‐methyladenosine‐dependent primary MicroRNA processing
    2016 690 citations Fu Yang, Qingguo Xu et al. Hepatology profile →
  4. Identification of miRNomes in Human Liver and Hepatocellular Carcinoma Reveals miR-199a/b-3p as Therapeutic Target for Hepatocellular Carcinoma
    2011 600 citations Weiping Zhou et al. profile →
  5. Circular RNA cSMARCA5 inhibits growth and metastasis in hepatocellular carcinoma
    2018 574 citations Qingguo Xu, Yuan Yang et al. profile →
  6. Long noncoding RNA high expression in hepatocellular carcinoma facilitates tumor growth through enhancer of zeste homolog 2 in humans
    2011 563 citations Fu Yang, Shengxian Yuan et al. Hepatology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Weiping Zhou China 50 8.6k 7.6k 1.8k 1.7k 1.6k 225 12.7k
Mengchao Wu China 59 4.8k 0.6× 3.8k 0.5× 3.5k 1.9× 3.3k 2.0× 5.2k 3.3× 312 13.7k
Dino Amadori Italy 60 4.5k 0.5× 4.3k 0.6× 1.6k 0.9× 823 0.5× 855 0.5× 351 14.2k
Alice P. Chen United States 50 4.7k 0.5× 2.8k 0.4× 891 0.5× 880 0.5× 434 0.3× 310 11.2k
Yang� Yang China 45 4.3k 0.5× 3.1k 0.4× 855 0.5× 801 0.5× 240 0.2× 379 7.6k
Antonio Russo Italy 55 4.7k 0.6× 3.2k 0.4× 1.2k 0.7× 768 0.5× 555 0.4× 371 11.9k
Philip A. Philip United States 57 4.1k 0.5× 3.5k 0.5× 1.8k 1.0× 1.2k 0.7× 695 0.4× 199 10.8k
Markus Guba Germany 38 3.0k 0.4× 1.3k 0.2× 2.0k 1.1× 1.3k 0.8× 1.3k 0.8× 194 8.5k
Tingbo Liang China 49 3.0k 0.4× 1.5k 0.2× 1.6k 0.9× 1.1k 0.6× 1.1k 0.7× 306 8.1k
Martin Pichler Austria 58 4.7k 0.5× 5.0k 0.7× 1.9k 1.1× 815 0.5× 222 0.1× 310 11.4k
Edwin P. Hui Hong Kong 47 2.2k 0.3× 2.2k 0.3× 2.1k 1.2× 1.1k 0.7× 951 0.6× 170 8.9k

Countries citing papers authored by Weiping Zhou

Since Specialization
Citations

This map shows the geographic impact of Weiping Zhou's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Weiping Zhou with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Weiping Zhou more than expected).

Fields of papers citing papers by Weiping Zhou

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Weiping Zhou. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Weiping Zhou. The network helps show where Weiping Zhou may publish in the future.

Co-authorship network of co-authors of Weiping Zhou

This figure shows the co-authorship network connecting the top 25 collaborators of Weiping Zhou. A scholar is included among the top collaborators of Weiping Zhou based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Weiping Zhou. Weiping Zhou is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhou, Weiping, Wei Zhou, R. T. Zhang, et al.. (2025). Integration of an AIE photosensitizer and a COX-2 inhibitor for synergistic and enhanced tumor therapy. Bioorganic Chemistry. 164. 108891–108891.
2.
Newton, Laura, Jialin Mao, Weiping Zhou, et al.. (2024). Association between tissue loss type and amputation risk among Medicare patients with concomitant diabetes and peripheral arterial disease. Journal of Vascular Surgery. 80(5). 1543–1552.e12. 3 indexed citations
3.
4.
Gan, Xiaojie, et al.. (2024). Collagen in hepatocellular carcinoma: A novel biomarker and therapeutic target. Hepatology Communications. 8(7). 6 indexed citations
5.
Huang, Qizhen, Kongying Lin, Hongbin Ji, et al.. (2023). Prognosis value of microscopic bile duct invasion in hepatocellular carcinoma: A multicenter study. Cancer Medicine. 12(22). 20821–20829. 2 indexed citations
6.
7.
Sun, Dapeng, Xiaojie Gan, Lei Liu, et al.. (2022). DNA hypermethylation modification promotes the development of hepatocellular carcinoma by depressing the tumor suppressor gene ZNF334. Cell Death and Disease. 13(5). 446–446. 16 indexed citations
8.
9.
Cao, Sanjie, David Zhang, Junhui Yuan, et al.. (2019). MicroRNA And Circular RNA Expression In Affected Skin Of Patients With Postherpetic Neuralgia. SHILAP Revista de lepidopterología. 1 indexed citations
10.
Zheng, Hao, et al.. (2019). Temporary Ischemia Time Before Snap Freezing Is Important for Maintaining High-Integrity RNA in Hepatocellular Carcinoma Tissues. Biopreservation and Biobanking. 17(5). 425–432. 8 indexed citations
11.
Yuan, Shengxian, Jie Wang, Yuan Yang, et al.. (2016). The Prediction of Clinical Outcome in Hepatocellular Carcinoma Based on a Six-Gene Metastasis Signature. Clinical Cancer Research. 23(1). 289–297. 27 indexed citations
12.
Yuan, Shengxian, et al.. (2015). Long noncoding RNA, the methylation of genomic elements and their emerging crosstalk in hepatocellular carcinoma. Cancer Letters. 379(2). 239–244. 38 indexed citations
13.
Yang, Yuan, Bo Huang, Ruoyu Wang, et al.. (2014). Pioglitazone, a PPARγ agonist, inhibits growth and invasion of human hepatocellular carcinoma via blockade of the rage signaling. Molecular Carcinogenesis. 54(12). 1584–1595. 49 indexed citations
14.
Tang, Liang, Yexiong Tan, Bei‐Ge Jiang, et al.. (2013). The Prognostic Significance and Therapeutic Potential of Hedgehog Signaling in Intrahepatic Cholangiocellular Carcinoma. Clinical Cancer Research. 19(8). 2014–2024. 51 indexed citations
15.
16.
Venkatraman, Giri, Donald S. Likosky, Daniel R. Morrison, et al.. (2011). Small Area Variation in Endoscopic Sinus Surgery Rates Among the Medicare Population. Archives of Otolaryngology - Head and Neck Surgery. 137(3). 253–253. 32 indexed citations
17.
Lau, Wan Yee, Eric C. H. Lai, Mengchao Wu, & Weiping Zhou. (2010). Preoperative Transarterial Chemoembolization for Resectable Large Hepatocellular Carcinoma. Annals of Surgery. 251(2). 386–387. 2 indexed citations
18.
Fanuele, Jason C., Jon D. Lurie, Weiping Zhou, Kenneth J. Koval, & James N. Weinstein. (2009). Variation in hip fracture treatment: are black and white patients treated equally?. PubMed. 38(1). E13–7. 7 indexed citations
19.
Zhou, Weiping. (2009). Effect of preoperative transcatheter arterial chemoembolization for treatment of resectable large hepatocellular carcinoma:a clinical randomized controlled trial. Academic Journal of Second Military Medical University. 1 indexed citations
20.
Li, Aijun, et al.. (2005). Diagnosis and Treatment of Liver Cystadenocarcinoma: Report of 18 Cases. The Chinese-German Journal of Clinical Oncology. 4(5). 267–270. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Mengchao Wu Breakdown of academic impact, for papers by Dino Amadori Breakdown of academic impact, for papers by Alice P. Chen Breakdown of academic impact, for papers by Yang� Yang Breakdown of academic impact, for papers by Antonio Russo Breakdown of academic impact, for papers by Philip A. Philip Breakdown of academic impact, for papers by Markus Guba Breakdown of academic impact, for papers by Tingbo Liang Breakdown of academic impact, for papers by Martin Pichler Breakdown of academic impact, for papers by Edwin P. Hui
Rankless by CCL
2026